Sat, Dec 27, 2014, 12:23 AM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Alimera Sciences, Inc. (ALIM) Message Board

  • yoshee_1007 yoshee_1007 Feb 28, 2012 7:24 AM Flag

    Aapproval of ILUVIEN(R) for the Trean

    Alimera Sciences Announces Positive Outcome to the European Decentralized Procedure for Approval of ILUVIEN(R) for the Treatment of Chronic Diabetic Macular Edema
    6:30a ET February 28, 2012 (GlobeNewswire)


    -- ILUVIEN(R) expected to be the first sustained release pharmaceutical in
    the European Union to treat diabetic macular edema (DME)
    -- ILUVIEN expected to be indicated for chronic DME considered
    insufficiently responsive to available therapies

 
ALIM
5.80+0.37(+6.81%)Dec 26 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Virgin America Inc.
NASDAQFri, Dec 26, 2014 4:00 PM EST
Rice Energy Inc.
NYSEFri, Dec 26, 2014 4:02 PM EST
Ocwen Financial Corp.
NYSEFri, Dec 26, 2014 4:03 PM EST